Insulet
PODD
#1041
Rank
NZ$31.47 B
Marketcap
$448.71
Share price
9.40%
Change (1 day)
70.31%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.81

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.88. In 2022 the company made an earnings per share (EPS) of $0.12 a decrease over its 2021 EPS that were of $0.39.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.812300.37%
2022$0.12-69.57%
2021$0.39109.09%
2020$0.18-38.89%
2019$0.30200%
2018$0.10-113.04%
2017-$0.77-9.8%
2016-$0.85-60.77%
2015-$2.1839.78%
2014-$1.5612.05%
2013-$1.39-23.15%
2012-$1.8110.2%
2011-$1.64-36.36%
2010-$2.58-36.63%
2009-$4.07-29.36%
2008-$5.76-86.74%
2007-$43.44-64.04%
2006-$120.80122.23%
2005-$54.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.38-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.41-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.64-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.58 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.98 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.55 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.09 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA